8-K filed June 2, 2026, 9:02 AM ET ticker ONCY CIK 0001129928

leadership confidence high sentiment neutral materiality 0.50

Oncolytics appoints Steve Glover to board, promotes John McAdory to COO

ONCOLYTICS BIOTECH INC

Steve Glover appointed to board effective June 1, 2026; he chaired Ambrx during its $2B J&J acquisition.
John McAdory promoted to COO effective June 1, 2026; previously EVP Strategy & Operations since Jan 2026.
McAdory will oversee clinical ops, preclinical R&D, strategic partnerships, and business development.
Glover receives an option to purchase 96,000 shares vesting over three years; McAdory receives no extra compensation.
Glover brings 35+ years biopharma experience; also chairs ZyVersa Therapeutics and sits on PDS Biotech board.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001129928-26-000039
form_type: 8-K
ticker: ONCY
cik: 0001129928
company_name: ONCOLYTICS BIOTECH INC
filed_at: 2026-06-02T13:02:48+00:00
discovered_at: 2026-06-02T13:04:00.256209+00:00
generated_at: 2026-06-02T13:04:11.303359+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001129928-26-000039
json_url: https://secwatch.observer/filing/0001129928-26-000039.json
markdown_url: https://secwatch.observer/filing/0001129928-26-000039.md
text_url: https://secwatch.observer/filing/0001129928-26-000039.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/oncy-20260602.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John McAdory

Chief Operating Officer

ONCY · ONCOLYTICS BIOTECH INC

Effective: 2026-06-01
Filed: June 2, 2026, 9:02 AM ET

appointed John McAdory as Chief Operating Officer of the Company

Appointed

Stephen Glover

Director

ONCY · ONCOLYTICS BIOTECH INC

Effective: 2026-06-01
Filed: June 2, 2026, 9:02 AM ET

appointed Stephen Glover as the ninth director of the Board

Source-grounded claims

51d737ca37

John McAdory was appointed as Chief Operating Officer at ONCOLYTICS BIOTECH INC.

appointed John McAdory as Chief Operating Officer of the Company

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

899e3fdee0

Stephen Glover was appointed as Director at ONCOLYTICS BIOTECH INC.

appointed Stephen Glover as the ninth director of the Board

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

ACRG

ACRG announces fractional executive transitions and new consultant for Nevada project

American Clean Resources Group, Inc. May 28, 2026, 8:45 PM ET leadership Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

Michael Raabe Effective February 2, 2026, Michael Raabe transitioned from his role as fractional Chief Operating Officer of the Company to a fractional strategic operations and project management support role.

Filing page SEC filing

ALH

COO International Jan Vleugels to retire Sept 30; Bob Calver named successor; new VP IR

Alliance Laundry Holdings Inc. June 2, 2026, 9:16 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

Mr. Jan Vleugals, Chief Operating Officer International of Alliance Laundry Holdings Inc. (the “Company”), provided notice of his decision to retire effective as of September 30, 2026

Filing page SEC filing

AHCO

AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant

AdaptHealth Corp. June 1, 2026, 9:02 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026

Filing page SEC filing

HON

Honeywell appoints Jill Evanko to Board of Directors, effective June 1, 2026

HONEYWELL INTERNATIONAL INC June 1, 2026, 8:12 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

Ms. Jillian Evanko, 48, Chief Executive Officer of Duravant LLC, has been appointed to serve as an Independent Director on the Company’s Board of Directors and a member of the Audit Committee, in each case, effective June 1, 2026.

Filing page SEC filing

TKNO

Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor

Alpha Teknova, Inc. June 1, 2026, 5:22 PM ET leadership Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.

Filing page SEC filing

WTTR

Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named

Select Water Solutions, Inc. June 1, 2026, 5:00 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,

Filing page SEC filing

LPX

LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026

LOUISIANA-PACIFIC CORP June 1, 2026, 4:31 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.

Filing page SEC filing

LOGC

ContextLogic appoints Scott Stewart as CFO & COO effective June 1; interim CFO resigns

ContextLogic Holdings Inc. June 1, 2026, 4:15 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

appointed John McAdory as Chief Operating Officer of the Company

Comparable filing

On June 1, 2026 the Company also announced the appointment of Scott Stewart, age 53, as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026 (the “Effective Date”).

Filing page SEC filing

Source: SEC EDGAR

accession 0001129928-26-000039

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.